STAAR Competitors
| STAA Stock | USD 28.55 1.87 7.01% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of STAAR Surgical competition on your existing holdings.
STAAR |
STAAR Surgical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between STAAR Surgical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of STAAR and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of STAAR Surgical does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between STAAR Stock performing well and STAAR Surgical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze STAAR Surgical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RMD | 1.19 | 0.13 | 0.02 | 0.67 | 1.55 | 2.14 | 12.38 | |||
| WST | 1.79 | (0.01) | 0.00 | 0.11 | 2.07 | 4.50 | 22.42 | |||
| ICUI | 1.17 | (0.09) | (0.06) | 0.04 | 1.33 | 2.77 | 7.25 | |||
| MMSI | 0.87 | 0.12 | 0.06 | 0.35 | 0.75 | 2.11 | 6.42 | |||
| MBOT | 2.14 | (0.04) | (0.04) | 0.01 | 2.36 | 5.38 | 15.87 | |||
| BDX | 0.83 | (0.15) | 0.00 | (0.10) | 0.00 | 1.49 | 7.77 | |||
| COO | 0.89 | 0.08 | 0.00 | 0.33 | 0.84 | 1.53 | 13.98 | |||
| HOLX | 0.89 | (0.05) | 0.00 | (0.04) | 0.00 | 1.81 | 8.14 | |||
| RGEN | 2.31 | (0.09) | (0.03) | 0.03 | 3.18 | 4.60 | 18.94 | |||
| HAE | 1.48 | 0.12 | 0.08 | 0.23 | 1.33 | 4.24 | 14.50 |
Cross Equities Net Income Analysis
Compare STAAR Surgical and related stocks such as ResMed Inc, West Pharmaceutical, and ICU Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | 800 K | 254.8 M | 307.1 M | 345.3 M | 352.9 M | 352.4 M | 342.3 M | 315.6 M | 404.6 M | 621.7 M | 474.5 M | 779.4 M | 897.6 M | 1 B | 1.1 B |
| WST | 15 M | 75.5 M | 80.7 M | 112.3 M | 127.1 M | 95.6 M | 143.6 M | 150.7 M | 206.9 M | 241.7 M | 346.2 M | 661.8 M | 585.9 M | 593.4 M | 623.1 M |
| ICUI | 3 M | 44.7 M | 41.3 M | 40.4 M | 26.3 M | 45 M | 63.1 M | 68.6 M | 28.8 M | 101 M | 86.9 M | 103.1 M | (74.3 M) | (29.7 M) | (28.2 M) |
| MMSI | (400 K) | 23 M | 19.7 M | 16.6 M | 23 M | 23.8 M | 20.1 M | 27.5 M | 42 M | 5.5 M | (9.8 M) | 48.5 M | 74.5 M | 94.4 M | 99.1 M |
| MBOT | (6.4 M) | (21.3 M) | (28.5 M) | (26.4 M) | (32.7 M) | (36.4 M) | (9.7 M) | (7.6 M) | (7.2 M) | (7.3 M) | (9.2 M) | (11.3 M) | 104.8 M | (10.7 M) | (11.3 M) |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.8 B |
| COO | 35.2 M | 248.3 M | 296.2 M | 269.9 M | 203.5 M | 273.9 M | 372.9 M | 139.9 M | 466.7 M | 238.4 M | 2.9 B | 385.8 M | 294.2 M | 338.3 M | 195.1 M |
| HOLX | 1.4 M | (73.6 M) | (1.2 B) | 17.3 M | 131.6 M | 330.8 M | 755.5 M | (111.3 M) | (40.2 M) | 1.1 B | 1.9 B | 1.3 B | 456 M | 789.5 M | 829 M |
| RGEN | (1.4 M) | (1.6 B) | 14.2 M | 16.1 M | 8.2 M | 9.3 M | 11.7 M | 28.4 M | 16.6 M | 21.4 M | 59.9 M | 128.3 M | 186 M | 41.6 M | 43.7 M |
| HAE | 18 M | 66.9 M | 38.8 M | 35.1 M | 16.9 M | (55.6 M) | (26.3 M) | 45.6 M | 55 M | 76.5 M | 79.5 M | 43.4 M | 115.4 M | 117.6 M | 123.4 M |
| NVST | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 272 M | 301.1 M | 230.7 M | 217.6 M | 33.3 M | 263.5 M | 243.1 M | (100.2 M) | (95.2 M) |
| ANGO | 343 K | (5.1 M) | (614 K) | 3.1 M | (3.3 M) | (44.5 M) | 7 M | 16.3 M | 61.3 M | (165.8 M) | (31.5 M) | (26.5 M) | (52.4 M) | (184.3 M) | (175.1 M) |
| ATR | 19.5 M | 183.7 M | 162.6 M | 172 M | 191.7 M | 199.3 M | 205.6 M | 220 M | 194.7 M | 242.2 M | 214 M | 244.1 M | 239.3 M | 284.5 M | 145.1 M |
STAAR Surgical and related stocks such as ResMed Inc, West Pharmaceutical, and ICU Medical Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in STAAR Surgical financial statement analysis. It represents the amount of money remaining after all of STAAR Surgical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.STAAR Surgical Competitive Analysis
The better you understand STAAR Surgical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, STAAR Surgical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across STAAR Surgical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
STAAR Surgical Competition Performance Charts
Five steps to successful analysis of STAAR Surgical Competition
STAAR Surgical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by STAAR Surgical in relation to its competition. STAAR Surgical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of STAAR Surgical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact STAAR Surgical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to STAAR Surgical, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your STAAR Surgical position
In addition to having STAAR Surgical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out STAAR Surgical Correlation with its peers. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.